Volume 68, Issue 1, Pages (July 2005)

Slides:

Advertisements

Similar presentations

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Advertisements

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 55, Issue 4, Pages (April 1999)

Volume 66, Issue 1, Pages (July 2004)

Volume 57, Issue 5, Pages (May 2000)

Beta blockers in the management of chronic kidney disease

Microalbuminuria, peripheral artery disease, and cognitive function

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

C-reactive protein and dialysis access

Volume 55, Issue 2, Pages (February 1999)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

C-reactive protein and dialysis access

Volume 77, Issue 1, Pages 6-8 (January 2010)

Volume 54, Issue 2, Pages (August 1998)

Volume 63, Issue 3, Pages (March 2003)

Steven J. Chadban, Natalie D. Staplin Kidney International

Malnutrition and inflammation in peritoneal dialysis patients

Volume 66, Issue 3, Pages (September 2004)

Comorbidity and confounding in end-stage renal disease

Volume 64, Issue 1, Pages (July 2003)

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 65, Issue 2, Pages (February 2004)

Stephen P. McDonald Kidney International Supplements

Acute myocardial infarction in patients with end-stage renal disease

Volume 70, Issue 12, Pages (December 2006)

Volume 89, Issue 5, Pages (May 2016)

Volume 61, Issue 2, Pages (February 2002)

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients Bernard G. Jaar, Brad C. Astor, Jeffrey S.

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Volume 68, Issue 2, Pages (August 2005)

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Volume 62, Issue 2, Pages (August 2002)

Volume 67, Issue 5, Pages (May 2005)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Volume 70, Issue 6, Pages (September 2006)

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 54, Issue 2, Pages (August 1998)

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 63, Issue 2, Pages (February 2003)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Long-term survival in renal transplant recipients with graft function

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 61, Issue 5, Pages (May 2002)

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

The Iranian model of living renal transplantation

Volume 87, Issue 1, Pages (January 2015)

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 72, Issue 2, Pages (July 2007)

Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease Sandra Amaral, Blayne A.

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Renal replacement therapy in Latin America

Volume 83, Issue 3, Pages (March 2013)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Volume 64, Issue 4, Pages (October 2003)

Volume 64, Issue 3, Pages (September 2003)

Volume 70, Issue 10, Pages (November 2006)

Volume 68, Issue 3, Pages (September 2005)

Familial phenotype differences in PKD11

Prediction in idiopathic membranous nephropathy

Volume 57, Pages S44-S48 (April 2000)

Presentation transcript:

Volume 68, Issue 1, Pages 217-227 (July 2005) C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial disease Carsten A. Boger, Angela Gotz, Mike Stubanus, Bernhard Banas, Martina Deinzer, Bernd Kruger, Stephan R. Holmer, Gerd Schmitz, Gunter A.J. Riegger, Bernhard K. Kramer Kidney International Volume 68, Issue 1, Pages 217-227 (July 2005) DOI: 10.1111/j.1523-1755.2005.00396.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier analysis of survival on hemodialysis therapy by peripheral arterial disease (PAD) status (N = 445). Log rank = 13.4,P = 0.0003. Kidney International 2005 68, 217-227DOI: (10.1111/j.1523-1755.2005.00396.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan-Meier analysis of survival on hemodialysis therapy by C-reactive protein (CRP). Evaluation by quartile (A) (N = 445). End point is all-cause mortality. Patients are censored for renal transplantation (N = 11), lost to follow-up (N = 2), or if alive on December 4, 2003 (N = 127). Triangles represent censored patients. Log rank = 18.43, df = 3,P = 0.0004. (B) Peripheral arterial disease stage IV (N = 190). End point is all-cause mortality (N = 147). Patients are censored for renal transplantation (N = 2), or if alive on December 4, 2003 (N = 41). Triangles represent censored patients. Log rank statistic = 10.7, df = 3,P = 0.01. (C) Patients with peripheral arterial disease other than Fontaine stage IV or without peripheral arterial disease (N = 255). End point is all-cause mortality (N = 158). Patients are censored for renal transplantation (N = 9), lost to follow-up (N = 2), or if alive on December 4, 2003 (N = 86). Triangles represent censored patients. Log rank = 3.72, df = 3,P = 0.29. Kidney International 2005 68, 217-227DOI: (10.1111/j.1523-1755.2005.00396.x) Copyright © 2005 International Society of Nephrology Terms and Conditions